BTIS
JAZZ icon

BB&T Investment Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

BB&T Investment Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$12K Buy
234
+199
+569% +$27.6K ﹤0.01% 924
2017
Q3 		$5K Buy
35
+15
+75% +$2.27K ﹤0.01% 941
2017
Q2 		$3K Buy
20
+16
+400% +$2.45K ﹤0.01% 937
2017
Q1 		$1K Buy
+4
New +$521 ﹤0.01% 993

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BB&T Investment Services's JAZZ Position: Q4 2017 in Review

BB&T Investment Services increased its Jazz Pharmaceuticals (JAZZ) stake by 569% in Q4 2017, buying an estimated $27.6K and bringing the position to 234 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

BB&T Investment Services first reported a position in JAZZ in Q1 2017 and has held it in 4 quarters since. 323 funds tracked by Wall St. Rank hold JAZZ as of Q4 2017.

  • BB&T Investment Services held 234 shares of Jazz Pharmaceuticals worth $12K as of Q4 2017.
  • BB&T Investment Services bought 199 Jazz Pharmaceuticals shares in Q4 2017, an estimated $27.6K.
  • Jazz Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #924 holding.
  • BB&T Investment Services first reported a position in Jazz Pharmaceuticals in Q1 2017 and has held it in 4 quarters since.
  • 323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.